This Article Figures Only Full Text Full Text (PDF) All Versions of this Article: j.jacc.2007.06.024v1 50/13/1205    most recent Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Web of Science (31) Citing Articles via Google Scholar Google Scholar Articles by Goldbarg, S. H. Articles by Fuster, V. Search for Related Content PubMed PubMed Citation Articles by Goldbarg, S. H. Articles by Fuster, V.

STATE-OF-THE-ART PAPER

Insights Into Degenerative Aortic Valve Disease

Zena and Michael A. Wiener Cardiovascular Institute and Marie-Josée and Henry R. Kravis Cardiovascular Health Center, The Mount Sinai School of Medicine, New York, New York.

Manuscript received April 26, 2007; revised manuscript received June 4, 2007, accepted June 12, 2007.

^_* Reprint requests and correspondence: Dr. Valentin Fuster, Zena and Michael A. Wiener Cardiovascular Institute, The Mount Sinai School of Medicine, One Gustave L. Levy Place, Box 1030, New York, New York 10029. (Email: valentin.fuster{at}mssm.edu).

Despite the dramatic decline of rheumatic heart disease over the past 5 decades, there has not been a concordant decline in the prevalence of valvular heart disease. Degenerative aortic valve disease (DAVD) has become the most common cause of valvular heart disease in the Western world, causing significant morbidity and mortality. No longer considered a benign consequence of aging, valve calcification is the result of an active process that, much like atherosclerotic vascular disease, is preceded by basement membrane disruption, inflammatory cell infiltration, and lipid deposition and is associated with diabetes, hypercholesterolemia, hypertension, and tobacco use. These realizations, in addition to pathological insights gained from emerging imaging modalities, have lead to the exploration of a variety of therapeutic interventions to delay or prevent the progression of DAVD. Inhibitors of 3-hydroxy-3-methylglutaryl-coenzyme A reductase, angiotensin-converting enzyme, and matrix metalloproteinase have all been studied as potential disease modifiers. Moreover, tissue engineering, aided by emerging stem cell technology, holds immense potential for the treatment of valvular heart disease as adjuncts to surgical interventions. Here we review the epidemiology and pathophysiology of DAVD, in addition to highlighting emerging therapeutic interventions for this growing problem.

Abbreviations and Acronyms   ACE = angiotensin-converting enzyme   BMP = bone morphogenic protein   CMR = cardiac magnetic resonance imaging   DAVD = degenerative aortic valve disease   LDL = low-density lipoprotein   MMP = matrix metalloproteinase   MSR = macrophage scavenger receptor   RANK = receptor activator of nuclear factor kappa B   TGF = transforming growth factor   TNF = tumor necrosis factor

This article has been cited by other articles:

				J. B. Grau, P. Poggio, R. Sainger, W. J. Vernick, W. F. Seefried, E. Branchetti, B. C. Field, J. E. Bavaria, M. A. Acker, and G. Ferrari Analysis of Osteopontin Levels for the Identification of Asymptomatic Patients With Calcific Aortic Valve Disease Ann. Thorac. Surg., January 1, 2012; 93(1): 79 - 86. [Abstract] [Full Text] [PDF]

				P. R. Moreno, L. Astudillo, S. Elmariah, K. R. Purushothaman, M. Purushothaman, P. A. Lento, S. K. Sharma, V. Fuster, and D. H. Adams Increased macrophage infiltration and neovascularization in congenital bicuspid aortic valve stenosis J. Thorac. Cardiovasc. Surg., October 1, 2011; 142(4): 895 - 901. [Abstract] [Full Text] [PDF]

				M. Nus, D. MacGrogan, B. Martinez-Poveda, Y. Benito, J. C. Casanova, F. Fernandez-Aviles, J. Bermejo, and J. L. de la Pompa Diet-Induced Aortic Valve Disease in Mice Haploinsufficient for the Notch Pathway Effector RBPJK/CSL Arterioscler Thromb Vasc Biol, July 1, 2011; 31(7): 1580 - 1588. [Abstract] [Full Text] [PDF]

				H. Akahori, T. Tsujino, Y. Naito, M. Matsumoto, M. Lee-Kawabata, M. Ohyanagi, M. Mitsuno, Y. Miyamoto, T. Daimon, H. Hao, et al. Intraleaflet haemorrhage is associated with rapid progression of degenerative aortic valve stenosis Eur. Heart J., April 1, 2011; 32(7): 888 - 896. [Abstract] [Full Text] [PDF]

				Z. Yu, K. Seya, K. Daitoku, S. Motomura, I. Fukuda, and K.-I. Furukawa Tumor Necrosis Factor-{alpha} Accelerates the Calcification of Human Aortic Valve Interstitial Cells Obtained from Patients with Calcific Aortic Valve Stenosis via the BMP2-Dlx5 Pathway J. Pharmacol. Exp. Ther., April 1, 2011; 337(1): 16 - 23. [Abstract] [Full Text] [PDF]

				S. Elmariah, J. A. C. Delaney, K. D. O'Brien, M. J. Budoff, J. Vogel-Claussen, V. Fuster, R. A. Kronmal, and J. L. Halperin Bisphosphonate Use and Prevalence of Valvular and Vascular Calcification in Women: MESA (The Multi-Ethnic Study of Atherosclerosis) J. Am. Coll. Cardiol., November 16, 2010; 56(21): 1752 - 1759. [Abstract] [Full Text] [PDF]

				S. Gielen, G. Schuler, and V. Adams Cardiovascular Effects of Exercise Training: Molecular Mechanisms Circulation, September 21, 2010; 122(12): 1221 - 1238. [Full Text] [PDF]

				W. S. Speidl, G. Cimmino, B. Ibanez, S. Elmariah, R. Hutter, M. J. Garcia, V. Fuster, M. E. Goldman, and J. J. Badimon Recombinant apolipoprotein A-I Milano rapidly reverses aortic valve stenosis and decreases leaflet inflammation in an experimental rabbit model Eur. Heart J., August 2, 2010; 31(16): 2049 - 2057. [Abstract] [Full Text] [PDF]

				Y. Matsumoto, V. Adams, S. Jacob, N. Mangner, G. Schuler, and A. Linke Regular Exercise Training Prevents Aortic Valve Disease in Low-Density Lipoprotein-Receptor-Deficient Mice Circulation, February 16, 2010; 121(6): 759 - 767. [Abstract] [Full Text] [PDF]

				M. A. Guerraty, G. R. Grant, J. W. Karanian, O. A. Chiesa, W. F. Pritchard, and P. F. Davies Hypercholesterolemia Induces Side-Specific Phenotypic Changes and Peroxisome Proliferator-Activated Receptor-{gamma} Pathway Activation in Swine Aortic Valve Endothelium Arterioscler Thromb Vasc Biol, February 1, 2010; 30(2): 225 - 231. [Abstract] [Full Text] [PDF]

				C. H. Yap, H.-S. Kim, K. Balachandran, M. Weiler, R. Haj-Ali, and A. P. Yoganathan Dynamic deformation characteristics of porcine aortic valve leaflet under normal and hypertensive conditions Am J Physiol Heart Circ Physiol, February 1, 2010; 298(2): H395 - H405. [Abstract] [Full Text] [PDF]

				F. Antonini-Canterin, E. Leiballi, M. Capanna, C. Burelli, M. Cassin, F. Macor, U. Grandis, and G. L. Nicolosi Association Between Carotid and Coronary Artery Disease in Patients With Aortic Valve Stenosis: An Angiographic Study Angiology, October 1, 2009; 60(5): 596 - 600. [Abstract] [PDF]

				P. Schoenhagen, E. M. Tuzcu, S. R. Kapadia, M. Y. Desai, and L. G. Svensson Three-dimensional imaging of the aortic valve and aortic root with computed tomography: new standards in an era of transcatheter valve repair/implantation Eur. Heart J., September 1, 2009; 30(17): 2079 - 2086. [Abstract] [Full Text] [PDF]

				S. H. Rahimtoola The Year in Valvular Heart Disease J. Am. Coll. Cardiol., May 19, 2009; 53(20): 1894 - 1908. [Full Text] [PDF]

				V. Kurra, P. Schoenhagen, E. E. Roselli, S. R. Kapadia, E. M. Tuzcu, R. Greenberg, M. Akhtar, M. Y. Desai, S. D. Flamm, S. S. Halliburton, et al. Prevalence of significant peripheral artery disease in patients evaluated for percutaneous aortic valve insertion: Preprocedural assessment with multidetector computed tomography. J. Thorac. Cardiovasc. Surg., May 1, 2009; 137(5): 1258 - 1264. [Abstract] [Full Text] [PDF]

				M. Akhtar, E. M. Tuzcu, S. R. Kapadia, L. G. Svensson, R. K. Greenberg, E. E. Roselli, S. Halliburton, V. Kurra, P. Schoenhagen, and S. Sola Aortic root morphology in patients undergoing percutaneous aortic valve replacement: Evidence of aortic root remodeling J. Thorac. Cardiovasc. Surg., April 1, 2009; 137(4): 950 - 956. [Abstract] [Full Text] [PDF]

				X. Yang, D. A. Fullerton, X. Su, L. Ao, J. C. Cleveland Jr, and X. Meng Pro-Osteogenic Phenotype of Human Aortic Valve Interstitial Cells Is Associated With Higher Levels of Toll-Like Receptors 2 and 4 and Enhanced Expression of Bone Morphogenetic Protein 2 J. Am. Coll. Cardiol., February 10, 2009; 53(6): 491 - 500. [Abstract] [Full Text] [PDF]

				Y. Matsumoto, V. Adams, C. Walther, C. Kleinecke, P. Brugger, A. Linke, T. Walther, F. W. Mohr, and G. Schuler Reduced number and function of endothelial progenitor cells in patients with aortic valve stenosis: a novel concept for valvular endothelial cell repair Eur. Heart J., February 1, 2009; 30(3): 346 - 355. [Abstract] [Full Text] [PDF]

				F. J. Schoen Evolving Concepts of Cardiac Valve Dynamics: The Continuum of Development, Functional Structure, Pathobiology, and Tissue Engineering Circulation, October 28, 2008; 118(18): 1864 - 1880. [Abstract] [Full Text] [PDF]

				B. A. Carabello Aortic Stenosis: It Is a Hot Topic: The Link to Coronary Artery Disease J. Am. Coll. Cardiol., August 26, 2008; 52(9): 764 - 766. [Full Text] [PDF]

				D. S. Jassal, J. W. Tam, K. M. Bhagirath, I. Gaboury, R. A. Sochowski, J. G. Dumesnil, P. J. Giannoccaro, J. Jue, A. S. Pandey, C. D. Joyner, et al. Association of mitral annular calcification and aortic valve morphology: a substudy of the aortic stenosis progression observation measuring effects of rosuvastatin (ASTRONOMER) study Eur. Heart J., June 2, 2008; 29(12): 1542 - 1547. [Abstract] [Full Text] [PDF]

				W. D. Merryman Insights Into (the Interstitium of) Degenerative Aortic Valve Disease J. Am. Coll. Cardiol., April 8, 2008; 51(14): 1415 - 1415. [Full Text] [PDF]

				S. H. Goldbarg, S. Elmariah, M. A. Miller, and V. Fuster Reply J. Am. Coll. Cardiol., April 8, 2008; 51(14): 1416 - 1416. [Full Text] [PDF]